Clinical Trials in Miami

Showing 4581-4600 of 7,502 trials

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

NCT01993186

The primary objectives of the study are to evaluate the efficacy of UX007 compared to placebo as measured by the reduction from randomization to Week 8 in frequency of seizures and to evaluate the safety of UX007 via adverse event (AE) rates, laboratory values, and electrocardiogram (ECG).

Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Ultragenyx Pharmaceutical Inc36 participantsStarted Feb 2014

Aurora, Colorado, United States • Miami, Florida, United States • Orlando, Florida, United States +11 more locations

COMPLETED< 1 mile

Urinalysis Results in Healthy Individuals

NCT04055675

This is a prospective, observational study assessing the results of urine dipsticks on adult volunteers with no acute symptoms. We seek to determine the frequency of leukocytes or nitrites in this group of individuals.

Asymptomatic BacteriuriaAsymptomatic Pyuria

Kendall Healthcare Group, Ltd.200 participantsStarted Jul 2019

Miami, Florida, United States

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Urinalysis Results in Healthy Individuals

Find Trials by Condition in Miami

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

Use Of Virtual Reality For Pain Control in Dermatological Bedside Procedures

Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program